Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

This publication has 22 references indexed in Scilit:

• Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy
  Journal of Clinical Oncology, 1999
• Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer.
  Journal of Clinical Oncology, 1997
• A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC
  British Journal of Cancer, 1996
• A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC
  Annals of Oncology, 1996
• A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer
  British Journal of Cancer, 1996
• A phase II trial with Docetaxel (Taxotere™) in second line treatment with chemotherapy for advanced breast cancer
  Annals of Oncology, 1994
• Doxorubicin in advanced breast cancer: Influence of schedule on response, survival and quality of life
  European Journal Of Cancer, 1992
• A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma
  British Journal of Cancer, 1987
• Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer
  European Journal of Cancer and Clinical Oncology, 1983
• Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
  Annals of Internal Medicine, 1979